department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Tybost · pharmadog

pharmadog
drugs
Tybost

drug

patient view →

cobicistat

Marketedupdated 2mo ago

by $GILD GILEAD SCIENCES, INC.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Tybost

generic

cobicistat

indication

Human Immunodeficiency Virus (HIV) Infections (AIDS)

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Aug 22, 2026

46 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (8)

Apr 6, 2033patentUS 10039718*PED
Apr 6, 2033patentUS 10039718*PED
Oct 6, 2032formulationUS 10039718
Oct 6, 2032formulationUS 10039718
Mar 3, 2030patentUS 8148374*PED3.7y
Mar 3, 2030patentUS 8148374*PED3.7y
Sep 3, 2029compositionUS 81483743.2y
Sep 3, 2029compositionUS 81483743.2y

FDA exclusivities (1)

Aug 22, 2026ODE-260Orphan Drug (7y)46d

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 5

tagApproval38 co-mentions · 19 sources
drug(cobicistat + darunavir)19 co-mentions · 19 sources
drug(cobicistat + darunavir) ODT19 co-mentions · 19 sources
tagSmall Molecule19 co-mentions · 19 sources
drugdarunavir1 co-mentions · 1 sources

Trials studying cobicistat

phase4A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatmentsrecruitingn=350
phase3Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIVactive not recruitingn=133
phase1A Study of the Effects of Food and Cobicistat on Plixorafenib Pharmacokinetics in Healthy Participants.completedn=28
phase2A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutationrecruitingn=447
—Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartumcompletedn=205
phase2ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancercompletedn=175
phase4A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participantscompletedn=8
phase1Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participantscompletedn=30

more trials →